title: [Expert opinion on APAP (prolonged action atypical antipsychotic agents). What are the limiting factors in resort to an APAP and how to overcome them].
authors.affiliation: Hôpital Sainte Anne, Pôle 16e, Secteur 75G17 (Dr Petitjean), Paris.
authors.forename: O
authors.initials: O
authors.lastname: Canceil
authors.forename: F
authors.initials: F
authors.lastname: Limosin
authors.forename: C
authors.initials: C
authors.lastname: Passerieux
mesh_terms: D000284:Administration, Oral; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001291:Attitude of Health Personnel; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D006801:Humans; D007273:Injections, Intramuscular; D010342:Patient Acceptance of Health Care / Q000523:psychology; D010353:Patient Education as Topic; D018570:Risk Assessment; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D055502:Secondary Prevention; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations